Intestinal epithelial PTPN23 is essential for gut barrier integrity and prevention of fatal bacterial translocation.

While treatment with the EGFR inhibitor gefitinib caused slight delays in weight loss and disease progression in KO mice ( Figure 5C ), these effects did not reach statistical significance.

also in 111,027 other papers